Network Pharmacology of Ayurveda Formulation Triphala with Special Reference to Anti-Cancer Property

被引:71
作者
Chandran, Uma [1 ]
Mehendale, Neelay [2 ]
Tillu, Girish [1 ]
Patwardhan, Bhushan [1 ]
机构
[1] Savitribai Phule Pune Univ, Interdisciplinary Sch Hlth Sci, Pune 411007, Maharashtra, India
[2] Savitribai Phule Pune Univ, Inst Bioinformat & Biotechnol, Pune 411007, Maharashtra, India
关键词
Ayurveda; bioactives; drug discovery; drug targets; network pharmacology; systems biology; Triphala; TRADITIONAL CHINESE MEDICINE; TYROSINE KINASE INHIBITOR; NATURAL-PRODUCTS; DRUG DISCOVERY; IN-VITRO; CANCER; CELLS; MET;
D O I
10.2174/1386207318666151019093606
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
Network pharmacology is an emerging technique, which integrates systems biology and computational biology to study multi-component and multi-targeted formulations. Ayurveda, the traditional system of Indian medicine, uses intelligent formulations; however, their scientific rationale and mechanisms remain largely unexplored. This paper presents the potential of network pharmacology to understand the rationale of a commonly used Ayurveda formulation known as Triphala. We have developed pharmacology networks of Triphala based on the information gathered from different databases and using the software Cytoscape. The networks depict the interaction of bioactives with molecular targets and their relation with diseases, especially cancer. The network pharmacology analysis of Triphala has offered new relationships among bioactives, targets and putative applications of cancer etiology. This pioneering effort might open new possibilities to know pharmacodynamics of Ayurvedic drugs like Triphala and also help in the discovery of new leads and targets for various diseases.
引用
收藏
页码:846 / 854
页数:9
相关论文
共 43 条
[1]
[Anonymous], 2013, PLoS ONE
[2]
The universal protein resource (UniProt) [J].
Bairoch, A ;
Apweiler, R ;
Wu, CH ;
Barker, WC ;
Boeckmann, B ;
Ferro, S ;
Gasteiger, E ;
Huang, HZ ;
Lopez, R ;
Magrane, M ;
Martin, MJ ;
Natale, DA ;
O'Donovan, C ;
Redaschi, N ;
Yeh, LSL .
NUCLEIC ACIDS RESEARCH, 2005, 33 :D154-D159
[3]
Plant-Based Rasayana Drugs from Ayurveda [J].
Balasubramani, Subramani Paranthaman ;
Venkatasubramanian, Padma ;
Kukkupuni, Subrahmanya Kumar ;
Patwardhan, Bhushan .
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2011, 17 (02) :88-94
[4]
Triphala, Ayurvedic Formulation for Treating and Preventing Cancer: A Review [J].
Baliga, Manjeshwar Shrinath .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2010, 16 (12) :1301-1308
[5]
Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy [J].
Campone, M. ;
Bondarenko, I. ;
Brincat, S. ;
Hotko, Y. ;
Munster, P. N. ;
Chmielowska, E. ;
Fumoleau, P. ;
Ward, R. ;
Bardy-Bouxin, N. ;
Leip, E. ;
Turnbull, K. ;
Zacharchuk, C. ;
Epstein, R. J. .
ANNALS OF ONCOLOGY, 2012, 23 (03) :610-617
[6]
Chandran U, 2015, P INDIAN NA IN PRESS
[7]
Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy [J].
Efferth, Thomas ;
Koch, Egon .
CURRENT DRUG TARGETS, 2011, 12 (01) :122-132
[8]
Girdhani S., 2005, J CANCER RES THER, V3, P129
[9]
The human disease network [J].
Goh, Kwang-Il ;
Cusick, Michael E. ;
Valle, David ;
Childs, Barton ;
Vidal, Marc ;
Barabasi, Albert-Laszlo .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (21) :8685-8690
[10]
Grüllich C, 2014, RECENT RESULTS CANC, V201, P207, DOI 10.1007/978-3-642-54490-3_12